Horizon Kinetics’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Horizon Kinetics’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,500	Closed	-$207K	–	507
2018 Q3	$207K	Buy	+4,500	New	+$182K	0.01%	462
2017 Q2	–	Sell	-4,500	Closed	-$66K	–	511
2017 Q1	$66K	Hold	4,500	–	–	﹤0.01%	495
2016 Q4	$64K	Hold	4,500	–	–	﹤0.01%	497
2016 Q3	$79K	Hold	4,500	–	–	﹤0.01%	500
2016 Q2	$77K	Hold	4,500	–	–	﹤0.01%	513
2016 Q1	$89K	Hold	4,500	–	–	﹤0.01%	514
2015 Q4	$86K	Hold	4,500	–	–	﹤0.01%	496
2015 Q3	$86K	Hold	4,500	–	–	﹤0.01%	491
2015 Q2	$209K	Hold	4,500	–	–	﹤0.01%	480
2015 Q1	$197K	Hold	4,500	–	–	﹤0.01%	493
2014 Q4	$156K	Hold	4,500	–	–	﹤0.01%	496
2014 Q3	$189K	Hold	4,500	–	–	﹤0.01%	488
2014 Q2	$264K	Hold	4,500	–	–	﹤0.01%	476
2014 Q1	$284K	Hold	4,500	–	–	﹤0.01%	465
2013 Q4	$263K	Hold	4,500	–	–	﹤0.01%	482
2013 Q3	$237K	Hold	4,500	–	–	﹤0.01%	488
2013 Q2	$346K	Buy	+4,500	New	+$367K	0.01%	359

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Horizon Kinetics's ARNA Position: Q4 2018 in Review

Horizon Kinetics sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2018, closing a stake of 4,500 shares — an estimated $207K sold.

Horizon Kinetics first reported a position in ARNA in Q2 2013 and held it in 17 quarters. The position peaked at $346K in Q2 2013. 177 funds tracked by Wall St. Rank hold ARNA as of Q4 2018.

Horizon Kinetics reported no remaining Arena Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Horizon Kinetics sold 4,500 Arena Pharmaceuticals Inc shares in Q4 2018, an estimated $207K.
Horizon Kinetics first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
Horizon Kinetics's Arena Pharmaceuticals Inc position peaked at $346K in Q2 2013.
177 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.